Clinical trial
Fenugreek: New Therapeutic Resource or Emerging Allergen
NCT06257797 is registered in ClinicalTrials.gov with Paola Miciullo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fenugreek: New Therapeutic Resource or Emerging Allergen
- Lead sponsor
- Paola Miciullo
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2022
- Completion date
- December 31, 2023
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fenugreek hypersensitivity - cross-reactivity - food allergy